Skip to main content

The Biomarker Company

SphingoTec develops and markets innovative IVD solutions for novel and proprietary blood-based protein biomarkers. Our aspiration is to effectively translate scientific advancements into routine clinical practice.

Our innovative biomarkers address diagnostically underserved acute and critical care conditions such as acute kidney injury, sepsis, and acute heart failure. The solutions we have created combine scientific discoveries with medical research and robust technologies to support clinicians in improving patient care. We work with internationally leading academic and non-academic medical centers as well as global IVD and pharma companies to bring these innovations closer to the patients. 

Innovative diagnostic solutions for unmet medical needs

Wide adoption

Commercial opportunities

We collaborate with a wide range of industry partners to convey the value of our biomarker innovations in clinical diagnostics and drug development.

Product portfolio

Biomarker-based diagnostics

We make our proprietary biomarkers available as CE IVD microtiter plate assays, a well-established technique suited for laboratories. 

From bench to bedside

Biomarker innovations

The main mortality drivers in intensive care units are diagnostic blind spots. We pave the way for early intervention and personalized medicine in acute and critical care with innovative biomarkers.


Latest News

26. March 2024
SphingoTec is pleased to announce the following appointments to its management team: Deborah Bergmann as Managing Director and Chief Executive Officer (CEO), Dr. Florian Uhle as Managing Director and Chief Medical Officer (CMO) and Nicole Witzmann as Chief Financial Officer (CFO).
Read more
05. October 2023
A new, improved formula has been developed for estimating the GFR using kidney function biomarker penKid. According to the data, penKid strongly correlates with the measured GFR (mGFR), while the penKid-based formula for estimating GFR performs better than routinely used equations.
Read more
06. September 2023
A new study and real-world data on the kidney function biomarker penKid underline its potential to monitor kidney function during acute kidney injury (AKI) and RRT and to support liberation decisions from RRT.
Read more

Events & Expos

19. - 22. March 2024

15:21 - 15:22

Brussels, Belgium

The International Symposium on Intensive Care and Emergency Medicine is organized by the Departments of Intensive Care and Emergency Medicine of Erasme University Hospital, Université Libre de…

Read more
14. - 16. February 2024

15:41 - 15:41

Bremen, Germany
The Symposium on Intensive Medicine and Intensive Care is a platform for professionals in the field to discuss current scientific findings, clinical developments, and standards in anesthesiology, intensive medicine, and intensive care.
Read more
17. - 19. January 2024

15:32 - 15:38

Berlin, Germany
The Forum for Interdisciplinary Intensive Medicine (FII) is a medical event aimed at experienced intensive care professionals.
Read more

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Follow our Journey on Social Media